Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies von WONG, P. C., CRAIN, E. J., XIN, B., WEXLER, R. R., LAM, P. Y. S., PINTO, D. J., LUETTGEN, J. M., KNABB, R. M.

Volltext

Identification of angiotensin II receptor subtypes von Chiu, Andrew T., Herblin, William F., McCall, Dale E., Ardecky, Robert J., Carini, David J., Duncia, John V., Pease, Lori J., Wong, Pancras C., Wexler, Ruth R., Johnson, Alexander L., Timmermans, Pieter B.M.W.M.

Volltext

Bisbenzamidine isoxazoline derivatives as factor Xa inhibitors von Quan, M.L., Pruitt, J.R., Ellis, C.D., Liauw, A.Y., Galemmo, R.A., Stouten, P.F.W., Wityak, J., Knabb, R.M., Thoolen, M.J., Wong, P.C., Wexler, R.R.

Volltext

S 1 heterocyclic thrombin inhibitors von Dominguez, C, Carini, D.J, Weber, P.C, Knabb, R.M, Alexander, R.S, Kettner, C.A, Wexler, R.R

Volltext

S1 heterocyclic thrombin inhibitors von DOMINGUEZ, C, CARINI, D. J, WEBER, P. C, KNABB, R. M, ALEXANDER, R. S, KETTNER, C. A, WEXLER, R. R

Volltext

Angiotensin II Receptor Heterogeneity von Herblin, William F., Chiu, Andrew T., McCall, Dale E., Ardecky, Robert J., Carini, David J., Duncia, John V., Pease, Lori J., Wong, Pancras C., Wexler, Ruth R., Johnson, Alexander L, Timmermans, Pieter B.M.W.M.

Volltext

Biaryl substituted alkylboronate esters as thrombin inhibitors von Quan, M.L., Wityak, J., Dominguez, C., Duncia, J.V., Kettner, C.A., Ellis, C.D., Liauw, A.Y., Park, J.M., Santella, J.B., Knabb, R.M., Thoolen, M.J., Weber, P.C., Wexler, R.R.

Volltext

Nonpeptide angiotensin II (AII) receptor antagonists: DMP 811, a 20-fold more potent orally-active antihypertensive agent than losartan (DUP 753) von Wong, P.C., Chiu, A.T., Ardecky, R.J., Carini, D.J., Wexler, R.R., Smith, R.D., Timmermans, P.B.M.W.M.

Volltext

Novel substituted arylhydroxamic acids as metalloproteinase inhibitors von M.E. VOSS, C.P. DECICCO, R.R. WEXLER

Volltext bestellen

Pharmacology of an active metabolite of DuP 753 — an orally-active nonpeptide angiotensin II receptor antagonist von Timmermans, P.B.M.W.M., Wong, P.C., Price, W.A., Chiu, A.T., Duncia, J.V., Carini, D.J., Wexler, R.R., Johnson, A.L.

Volltext

Using Nab to determine correlations in unpolarized neutron decay von Broussard, L.J, Baeßler, S, Bailey, T.L, Birge, N, Bowman, J.D, Crawford, C.B, Cude-Woods, C, Fellers, D.E, Fomin, N, Frlež, E, Gericke, M.T.W, Hayen, L, Jezghani, A.P, Li, H, Macsai, N, Makela, M.F, Mammei, R.R, Mathews, D, McGaughey, P.L, Mueller, P.E, Počanić, D, Royse, C.A, Salas-Bacci, A, Sjue, S.K.L, Ramsey, J.C, Severijns, N, Smith, E.C, Wexler, J, Whitehead, R.A, Young, A.R, Zeck, B.A

Volltext

Proteolysis and tyrosine phosphorylation of p34(cdc2)/cyclin B. The role of MCM2 and initiation of DNA replication to allow tyrosine phosphorylation of p34(cdc2) von Ye, X.S, Fincher, R.R, Tang, A, McNeal, K.K, Gygax, S.E, Wexler, A.N, Ryan, K.B, James, S.W, Osmani, S.A

Volltext

Contributors von Baechtold, W., Bandler, J.W., Bulley, R., Cambrell, G.K., Carlin, H.J., Carson, C.T., Cermak, I.A., Cohen, G.H., Dalley, J.E., Davies, J.B., Govaerts, R.J.M., Green, H.E., Green, P.E., Gupta, O.P., Gupta, R.R., Houston, T.W., Kammler, D.W., Karnik, A.R., Kotyczka, W., Kozemchak, E.B., Laloux, A.A., Macdonald, P.A., Macnee, A.B., Mahdi, S., McPhun, M.K., Molberg, J.R., Murray-Lasso, M.A., Parker, W.N., Read, L.W., Reynolds, D.K., Silvester, P., Sinnott, D.H., Smoll, A.E., Strutt, M.J.O., Thomas, D.T., Toussaint, H., Tu, P.J., Vander Vorst, A.S., Wexler, A.

Volltext